Syncona Limited (SYNC.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 09:20AM BST. Market open.
| Previous close | 126.00 |
| Open | 125.00 |
| Bid | 124.00 x 0 |
| Ask | 127.00 x 0 |
| Day's range | 124.00 - 125.30 |
| 52-week range | 105.00 - 188.20 |
| Volume | |
| Avg. volume | 761,310 |
| Market cap | 810.112M |
| Beta (5Y monthly) | 0.25 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.25 |
| Earnings date | 20 Jun 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 20 Jun 2019 |
| 1y target est | 245.33 |
ZacksFreeline (FRLN) Shares Rise on Merger Agreement With Syncona
Freeline Therapeutics (FRLN) is set to be acquired by Syncona Ltd. The transaction is expected to be closed in the first quarter of 2024. Shares rise.
Globe NewswireSyncona to Acquire Freeline Therapeutics
Freeline shareholders to receive $6.50 per American Depositary Share, a 51% premium over closing price prior to announcement of Syncona’s initial proposal on October 18, in an all-cash transaction Based on extensive evaluation of available strategic and financing options, Freeline’s independent directors unanimously recommend transaction as best value for shareholders Syncona to provide $15 million in convertible debt financing to cover Freeline’s near-term capital needs and support ongoing adva
© 2024 Yahoo. All rights reserved.